Understanding maternal health outcomes
Critical to ensuring the well-being of both pregnant women and babies is an understanding of how various medications may affect them. Yet evidence can be difficult to find. Optum® Dynamic Assessment of Pregnancies and Infants (DAPI) links women and their infants’ health data to answer questions about maternal health.
The resulting database allows researchers to track women's exposures and the medications they took before and during pregnancy, then link those exposures to infants in utero. We examine these exposures in relation to pregnancy outcomes and infant health outcomes.
Linking women and their infant's health data
Our extensive database empowers patients and providers with critical decision-making tools.
Growing depth of data
Our database includes approximately 200,000 pregnancies per calendar year.
Help patients and providers make decisions
Tap into our connected claims and medical records databases to contribute to public health knowledge.
Support regulatory agencies
Meet regulatory standards and requests for drug labeling.
Pregnancy attributes
Discover data variables that may be of interest as we work together to address your study objectives.
Related healthcare insights
Article
See how the FDA and Optum use real-world evidence to monitor the safety and effectiveness of COVID-19 vaccines in our youngest populations.
Guide
As a key FDA collaborator, Optum Epidemiology generates reproducible results that inform regulatory decisions for COVID-19 vaccines.
E-book
Life sciences market experts from Optum and Advisory Board share perspectives on trends that will influence the future drug value chain.